ConductScience.org, home

Paper22345482

Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.

Salamon D and 8 others. J Virol, 2012. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells. Papers, record 22345482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22345482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells.
PubMed
Journal
J Virol
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2021-10-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Salamon DDaniel
2Adori MMonika
3Ujvari DDorina
4Wu LLiang
5Kis LLLorand L
6Madapura HSHarsha S
7Nagy NNoemi
8Klein GGeorge
9Klein EEva

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B-LymphocytesMajor topic
Herpesvirus 4, HumanMajor topic
Interferon Type IMajor topic
Viral Matrix ProteinsMajor topic
Cell Line
Gene Expression Regulation, Viral
Humans
Molecular Sequence Data
Promoter Regions, Genetic
Signal Transduction
Transcription, Genetic
Virus Latency

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11832772Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isoform of protein kinase C in Daudi cells.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1832772PubMed
26161964
The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon.
J Immunol1981https://conductscience.org/library/papers/6161964PubMed
322204827Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.Cytokine2012https://conductscience.org/library/papers/22204827PubMed
424709245-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.J Virol1989https://conductscience.org/library/papers/2470924PubMed
56291233Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation.Virology1982https://conductscience.org/library/papers/6291233PubMed
62479717The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.J Gen Virol1989https://conductscience.org/library/papers/2479717PubMed
711405234Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.Biol Chem2001https://conductscience.org/library/papers/11405234PubMed
819720839Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.J Exp Med2009https://conductscience.org/library/papers/19720839PubMed
97769727The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.J Virol1995https://conductscience.org/library/papers/7769727PubMed
108386282Inhibition of Epstein-Barr virus-mediated capping of CD21/CR2 by alpha interferon (IFN-alpha): immediate antiviral activity of IFN-alpha during the early phase of infection.J Virol1993https://conductscience.org/library/papers/8386282PubMed
1112219084Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.Nat Med2002https://conductscience.org/library/papers/12219084PubMed
1220876453
STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma.
Blood2011https://conductscience.org/library/papers/20876453PubMed
1316332968IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.Blood2006https://conductscience.org/library/papers/16332968PubMed
141371012Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1371012PubMed
152848918B cell activation and the establishment of Epstein-Barr virus latency.J Exp Med1988https://conductscience.org/library/papers/2848918PubMed
1610777558Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.J Biol Chem2000https://conductscience.org/library/papers/10777558PubMed
172580994Effects of pure interferons on Epstein-Barr virus infection in vitro.J Virol1985https://conductscience.org/library/papers/2580994PubMed
188178450Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions.Virology1994https://conductscience.org/library/papers/8178450PubMed
192439466Anti-proliferative effects of interferons on Daudi Burkitt lymphoma cells: induction of cell differentiation and loss of response to autocrine growth factors.Int J Cancer1987https://conductscience.org/library/papers/2439466PubMed
2020080768IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20080768PubMed

See all 47 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
33613527Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity.Front Immunol2020https://conductscience.org/library/papers/33613527PubMed
33329556Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells.Front Immunol2020https://conductscience.org/library/papers/33329556PubMed
32463796Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-κB pathway.Aging (Albany NY)2020https://conductscience.org/library/papers/32463796PubMed
28663145Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas.EBioMedicine2017https://conductscience.org/library/papers/28663145PubMed
26819314Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.J Virol2016https://conductscience.org/library/papers/26819314PubMed
26579121The Role of Latently Infected B Cells in CNS Autoimmunity.Front Immunol2015https://conductscience.org/library/papers/26579121PubMed
26530011EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.Leukemia2016https://conductscience.org/library/papers/26530011PubMed
26424647EBV Persistence--Introducing the Virus.Curr Top Microbiol Immunol2015https://conductscience.org/library/papers/26424647PubMed
23760364Characterization of human Fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications.Oncol Lett2013https://conductscience.org/library/papers/23760364PubMed
23342374Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.Viruses2012https://conductscience.org/library/papers/23342374PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
PDLIM79260PubTator's text mininghttps://conductscience.org/library/genes/9260NCBI Gene

Download CSV of genes

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKHE653895GENBANK
GENBANKHE653896GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22345482

GET https://conductscience.org/api/papers/v1/22345482/references?page=2